Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults

Metabolism: Clinical and Experimental

Volumn 57, Issue 9, 2008, Pages 1181-1189

  Kim, Kijin ^a   Valentine, Rudy J ^b   Shin, Yoonjung ^a   Gong, Kyungmin ^a  

^a Keimyung University   (South Korea)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; LEPTIN;

ABDOMINAL FAT; ADULT; ANTHROPOMETRY; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY FAT; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; FITNESS; HEALTH PROMOTION; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADULT; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; C-REACTIVE PROTEIN; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; EXERCISE; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 48849105133     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.009     Document Type: Article

References (54)

1. Despres J.P. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl 6 (2006) B4-B12
2. Yudkin S.J., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
3. Libby P., and Ridker P.M. Maseri A.Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
5. Lemieux I., Pascot A., Prud'homme D., Almeras N., Bogaty P., Nadeau A., et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21 (2001) 961-967
6. Diamant M., Lamb H.J., van de Ree M.A., Endert E.L., Groeneveld Y., Bots M.L., et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metabolism 90 (2005) 1495-1501
7. Caballero A.E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11 (2003) 1278-1289
8. Gullum R.F. Epidemiology of hypertension in African American women. Am Heart J 131 (1996) 385-395
9. Huang T.K., Johnson M.S., Figueroa-Colon R., Dwyer J.H., and Goran M.I. Growth of visceral fat, subcutaneous fat, and total body fat in children. Obes Res 9 (2001) 283-289
10. Lovejoy J.C., de la Bretonne J.A., Klemperer M., and Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45 (1996) 1119-1124
11. Racette S.B., Horowitz J.F., Mittendorfer B., and Klein S. Racial differences in lipid metabolism in women with abdominal obesity. Am J Physiol 279 (2000) R944-R950
12. Weinsier R.L., Hunter G.R., Gower B.A., Schutz Y., Darnell B.E., and Zuckerman P.A. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 74 (2001) 631-636
13. Cheung B.M. The cardiovascular continuum in Asia-a new paradigm for the metabolic syndrome. J Cardiovascular Pharmacol 46 (2005) 125-129
14. Gavaler J.S., and Rosenblum E. Predictors of postmenopausal body mass index and waist hip ratio in the Oklahoma postmenopausal health disparities study. J Am Coll Nutri 22 (2003) 269-276
15. Geffken D.F., Cushman M., Burke G.L., Polak J.F., Sakkinen P.A., and Tracy R.P. Association between physical activity and markers of inflammation in a health elderly population. Am J Epidemiology 153 (2001) 242-250
16. Kohur M.L., McCann D.A., Russell D.W., Konopka D.N., Cunnick J.E., Franke W.D., et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 20 (2006) 201-209
17. Aronson D., Sella R., Sheikh-Ahmad M., Kerner A., Avizohar O., Rispler S., et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol 44 (2004) 2003-2007
18. Hammett C.J.K., Prapavessis H., Baldi J.C., Varo N., Schoenbeck U., Ameratunga R., et al. Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk. Am Heart J 151 (2006) 367e7-367e16
19. Oberbach A., Tonjes A., Kloting N., Fasshauer M., Kratzsch J., Busse M.W., et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 154 (2006) 577-585
20. Kim K., Lee W., Lee S., Ahn N., Oh H., Shin Y., et al. Health status and lifestyle including diet, exercise, and daily activities in obese adults. Kor J Sports Med 23 (2005) 54-63
21. Jackson A.S., Pollock M.L., and Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc 12 (1980) 175-182
22. Siri W.E. Body composition from fluid spaces and density: analysis of methods. In: Brozek J., and Henschel A. (Eds). Techniques for measuring body composition (1961), National Academy of Sciences National Research Council, Washington (DC) 223-244
23. WHO. Report of a WHO Consultation on obesity: preventing and managing. In the global epidemic (1999) [Geneva]
24. Friedewald W.T., Levy R.I., and Fredreickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
25. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17 (1957) 237-246
26. Matthew D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. Brouha L., Graybiel A., and Heath C.W. The step test: a simple method of measuring physical fitness for hard muscular work in adult man. Revue Canadienne de Biologie 2 (1943) 86-92
28. Duncan B.B., Chambless L.E., Schmidt M.I., Szklo M., Folsom A.R., Carpenter M.A., et al. Correlates of body fat distribution: variation across categories of race, sex, and body mass in the Atherosclerosis Risk in Communities Study. Ann Epidemiol 5 (1995) 192-200
29. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., and Despres J.P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 58 (1993) 463-467
30. McGill H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al., for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002) 2712-2718
31. Festa A., D'Agostino Jr. R., Howard G., Mykkanaen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
32. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
33. Hak A.E., Stehouwer C.D.A., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendorp I.C.D., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
34. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90 (2005) 4145-4150
35. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., and Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
36. Pirro M., Schillaci G., Savarese G., Gemelli F., Vaudo G., Siepi D., et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest 34 (2004) 335-341
37. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Cir Res 89 (2001) 763-771
38. Woollard K.J., Phillips D.C., and Griffeiths H.R. Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells. Clin Exp Immunol 130 (2002) 256-262
39. Montero I., Orbe J., Varo N., Beloqui O., Monreal J.I., Rodriguez J.A., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 (2006) 1369-1378
40. Yun Z., Shu-Hong L., Shi-Ming L., Paul E.S., Xiao-Qing H., Paul W.M.F., et al. C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48 (2006) 504-511
41. Kahn S.E., Zinman B., Haffner S.M., O'Neill M.C., Kravitz B.G., Yu D., et al., the ADOPT Study Group. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55 (2006) 2357-2364
42. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
43. Corica F., Allegra A., Corsonello A., Buemi M., Calapai G., Ruello A., et al. Relationship between plasma leptin levels and the tumor necrosis factor-a system in obese subjects. Int J Obes Relat Metab Disord 23 (1999) 355-360
44. Mendoza-Nunez V.M., Garcia-Sanchez A., Sanchez-Rodriguez M., Galvan-Duarte R.E., and Fonseca-Yerena M.E. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obesity Res 10 (2002) 253-259
45. Singhal A., Farooqi I.S., Cole T.J., O'Rahilly S., Fewtrell M., Kattenhorn M., et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 106 (2002) 1919-1924
46. Boreham C.A., Ferreira I., Twisk J.W., Gallagher A.M., Savage M.J., and Murray L.J. Cardiorespiratory fitness, physical activity, and arterial stiffness: the northern Ireland young hearts project. Hypertension 44 (2004) 721-726
47. Stevenson E.T., Davy K.P., and Seals D.R. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women. Arterioscler Thromb Vasc Biol 15 (1995) 669-677
48. Christou D.D., Gentile C., DeSouza C.A., Seals D.R., and Gates P.E. Fatness is a better predictor of cardiovascular disease risk factor profiles than aerobic fitness in healthy men. Circulation 111 (2005) 1904-1914
49. Wolfe L., Martin R., Watson D., Lasley R.D., and Bruns D.E. Chronic exercise and left ventricular structure and function in healthy human subjects. J Appl Physiol 58 (1985) 409-415
50. MacAuley D., McCrum E.E., Stott G., Evans A.E., McRoberts B., Boreham C.A., et al. Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey. J Epidemiol Community Health 50 (1996) 258-263
51. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 78 (2005) 819-835
52. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edward P.A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
53. Wick G., Romen M., Amberger A., Metzler B., Mayr M., Falkensammer G., et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J 11 (1997) 1199-1207
54. Astrup A. Physical activity and weight gain and fat distribution changes with menopause: current evidence and research issues. Med Sci Sports Exerc 31 (1999) S564-S567